drug repurposing Archive — Page 1 of 2

Close-up, softly focused photograph of a pregnant person’s abdomen with one hand resting on the belly; the person’s face is not visible.
September 23, 2026

Vanderbilt Health study identifies drugs with potential to improve outcomes associated with preterm labor

The findings do not mean that these drugs are ready to be used clinically for preterm labor; rather, they identify promising candidates for further development.

By Evan Dorian
August 4, 2026

Research that reaches patients: A conversation with Wesley Self and Jill Pulley

Research and art both approach the world with a fresh perspective. This art gallery features work by undergraduate student artists who participated in the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. Supported by the Burroughs Wellcome Fund, the VI4-AiR program brings together scientists and artists to create and promote art as a visual science communication tool.

Five members of a research team pose in a laboratory, surrounded by shelves of supplies and scientific equipment. Jerod Denton stands in the center, with Kangjun Li, Samantha Le, Vaishali Satpute and Roman Lazarenko beside him.
June 25, 2026

Common asthma drugs may help guide new treatments for Parkinson’s disease

New research findings suggest that drugs approved by the Food and Drug Administration for other conditions might be repurposed to restore normal cell function in neurodegenerative disorders such as Parkinson’s disease.

By Bill Snyder
Stylized glowing anatomical heart surrounded by blue particles, with two open capsules releasing particles above it.
June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

By Bill Snyder
Three people stand in the Vanderbilt Clinical Research Center beside a wall sign reading “Clinical Research Center.”
April 20, 2026

Drug lifts ‘brain fog’ from lupus patients: Clinical trial

An estimated 200,000 people in the United States have lupus. About 80% of them experience “brain fog,” cognitive problems that impair learning, memory and attention. The EG501 study was the inaugural project of Vanderbilt Health’s Drug Repurposing program.

By Bill Snyder
Futuristic medical illustration showing a tablet with glowing DNA strands, three medicine vials, a syringe, a human figure, a DNA icon, and a magnifying glass on a digital blue interface.
December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

By Leigh MacMillan